[Delayed hypersensitivity reaction to 2,4-dinitrochlorobenzol in cancer patients undergoing cytostatic chemotherapy].
D000367:Age Factors; D000368:Aged; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D004336:Drug Antagonism; D050723:Fractures, Bone / Q000188:drug therapy; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced / Q000276:immunology*; D007165:Immunosuppression Therapy; D008223:Lymphoma / Q000188:drug therapy; D008727:Methotrexate / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D009578:Nitrobenzenes / Q000494:pharmacology*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D014652:Vascular Diseases / Q000188:drug therapy
D009578:Nitrobenzenes; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate
Die kutan-allergische Spätreaktion auf 2,4-Dinitrochlorbenzol bei Krebspatienten unter zytostatischer Chemotherapie.